The ROE as of December 2025 (TTM) for ADC Therapeutics S.A. (ADCT) is 82.24%

According to ADC Therapeutics S.A.’s latest financial reports and current stock price. The company's current ROE is 82.24%. This represents a change of 450.02% compared to the average of 14.95% of the last 4 quarters.

ADC Therapeutics S.A. (ADCT) Historical ROE (quarterly & annually)

How has ADCT ROE performed in the past?

The mean historical ROE of ADC Therapeutics S.A. over the last ten years is -45.17%. The current 82.24% ROE has changed -282.05% with respect to the historical average. Over the past ten years (40 quarters), ADCT's ROE was at its highest in in the June 2023 quarter at 548.57%. The ROE was at its lowest in in the March 2023 quarter at -157.69%.

ADC Therapeutics S.A. (ADCT) ROE by Quarter and Year

Discovering the peaks and valleys of ADC Therapeutics S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ADC Therapeutics S.A. (ADCT) Average ROE

How has ADCT ROE performed in the past?

The current ROE of ADC Therapeutics S.A. (ADCT) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ADC Therapeutics S.A. (ADCT) ROE vs. Peers

How is ADCT’s ROE compared to its peers?

ADC Therapeutics S.A.’s ROE is less than Omeros Corporation (57.33%), greater than Neumora Therapeutics, Inc. Common Stock (-113.81%), greater than RAPT Therapeutics, Inc. (-61.81%), greater than Autolus Therapeutics plc (-56.18%), greater than Alumis Inc. Common Stock (-75.52%), greater than Bicycle Therapeutics plc (-35.54%), greater than Lexicon Pharmaceuticals, Inc. (-83.63%), greater than 4D Molecular Therapeutics, Inc. (-47.27%), greater than Lineage Cell Therapeutics, Inc. (-119.44%), greater than Quantum-Si incorporated (-47.64%),

Build a custom stock screener for ADC Therapeutics S.A. (ADCT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ADC Therapeutics S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ADC Therapeutics S.A. (ADCT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ADC Therapeutics S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.